Clinical Trials news and clinical updates, with links to original sources.
In a small eight-week randomized trial, neither medication clearly outperformed the other, though symptom changes and side effects differed.
A new review finds encouraging animal research on CBD, but mixed and mostly negative results so far in people.
A journal listing describes a randomized trial involving parents with ADHD and their children, but the supplied information does not report what happened.
A planned study will examine whether a nurse-led family program can ease trauma-related stress symptoms.
A broad review found controlled studies have not shown higher risks of suicidality or major psychiatric harm, while questions remain for some vulnerable groups.
A randomized trial found that a 2-minute, 40-second animated story modestly lowered reported stigma toward people with addiction, especially when paired with sound.
A systematic review found that few potential medicines have been tested across the full path from early research to clinical trials.
A three-month study found that many Oregon clients reported improved mental health and well-being, but it cannot prove the services caused those changes.
A preprint study of 2,363 clients at regulated Oregon and Colorado service centers tracked self-reported outcomes two weeks after psilocybin sessions.
A large English trial found that a relationship-focused approach to crisis mental health care improved several experiences of care, while its main relapse measure did not change.
A planned study will compare basketball, badminton and structured aerobic activity, each paired with mindfulness training.
Auvelity is now an FDA-approved, non-antipsychotic option for adults with agitation associated with Alzheimer’s dementia.